Saturday 17 October 2026
Export TSEOQ’s income statement to Excel — free account
Trinseo PLC
TSEOQ Basic Materials Specialty Chemicals
Trinseo PLC’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, down 15.3% from fiscal 2024. In the quarter to June 2026, revenue grew 7.79%, EPS fell 10.9%, free cash flow fell 4,036.7% and total debt fell 76.3%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow TSEOQ
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.00 | 0.00 | 0.01 | 0.03 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | (0.02) | 0.79 | (3.92) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.14 | 0.91 | 0.81 | 0.80 | |
EV/EBITDA |
5.16 | 39.36 | 49.83 | 24.88 | |
EV/Operating CF |
(1.18) | (11.84) | (23.60) | (62.54) | |
EV/FCF |
(1.04) | (9.69) | (15.75) | (23.93) | |
Quick Ratio |
0.66 | 0.17 | 0.72 | 0.76 | |
Current Ratio |
1.17 | 0.29 | 1.21 | 1.37 | |
Net Debt/EBITDA |
10.00 | 91.76 | (112.09) | 78.02 | |
Debt/Assets |
23.67% | 120.01% | 111.63% | 101.25% | |
Debt/Equity |
(0.44) | (2.27) | (2.32) | (2.93) | |
Asset Turnover |
1.16 | 1.17 | 1.21 | 1.17 | |
Operating CF/Net income |
0.96 | 2.01 | (0.09) | 0.20 | |
Capex/Depreciation |
(0.22) | (0.15) | (0.11) | (0.28) | |
Interest Coverage |
0.00 | (0.30) | (2.44) | (0.40) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.92% | 12.06% | 27.88% | 8.50% | |
Intangible Assets out of Total Assets |
0.20 | 0.23 | 0.25 | 0.24 | |
Share Based Compensation of Revenue |
0.09% | (0.01%) | 0.11% | 0.20% | |
Graham Net Nets |
0.00 | (650.05) | (140.41) | (28.73) | |
Graham Number |
116.90 | 110.90 | 102.41 | 78.86 | |
Earnings Yield |
0.00% | (14,709.09%) | (3,040.00%) | (491.49%) | |
Free Cash Flow Yield |
0.00% | (6,908.59%) | (856.98%) | (123.29%) | |
Revenue per Share |
23.10 | 20.02 | 18.51 | 20.64 | |
Operating CF per Share |
(3.15) | (6.43) | 0.63 | (0.60) | |
Capex per Share |
(0.24) | (0.21) | (0.45) | (0.46) | |
Free Cash Flow per Share |
(3.39) | (6.65) | 0.18 | (1.06) | |
Cash per Share |
4.96 | 3.06 | 4.10 | 3.11 | |
Shareholders Equity per Share |
(36.81) | (33.78) | (30.66) | (23.93) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(36.81) | (33.78) | (30.66) | (23.93) | |
Free Cash Flow |
(124.10) | (240.60) | 6.60 | (38.10) | |
Working Capital |
166.70 | (2,256.80) | 150.00 | 248.20 | |
Capital Expenditures |
(8.80) | (7.70) | (16.00) | (16.50) | |
Net Current Asset Value |
(2,679.90) | (2,588.50) | (2,513.30) | (2,430.90) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
455.65 | 448.35 | 372.20 | 438.55 | |
Average Payables |
281.55 | 269.15 | 273.50 | 338.95 | |
Average Inventory |
384.35 | 353.55 | 331.60 | 393.10 | |
Average Assets |
2,565.25 | 2,482.15 | 2,462.15 | 2,687.25 | |
Average Common Equity |
(1,048.75) | (951.05) | (858.85) | (670.80) |
Columns are period end dates